{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:03:14Z","timestamp":1784775794824,"version":"3.55.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002349","name":"Egyptian Academy of Scientific Research and Technology","doi-asserted-by":"crossref","award":["FRM-SGO-CYCL#8"],"award-info":[{"award-number":["FRM-SGO-CYCL#8"]}],"id":[{"id":"10.13039\/501100002349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05250-8","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:52:14Z","timestamp":1776750734000},"page":"15163-15182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Co-treatment of Colchicine and Rosiglitazone synergistically inhibits cytokine-driven inflammation and modulates the related hsa-miRNA26a-5p, hsa-miRNA21-5p, and STAT3 expression in non-small cell lung cancer"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9830-9001","authenticated-orcid":false,"given":"Nayera","family":"Younes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omayma","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6568-1757","authenticated-orcid":false,"given":"Ahmed","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"5250_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1749-6632.2009.04911.x","volume":"1171","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S, Sung B (2009) Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 1171:59\u201376. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04911.x","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"5250_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101434","volume":"5","author":"MM Alruwaili","year":"2024","unstructured":"Alruwaili MM, Zonneville J, Naranjo MN, Serio H, Melendy T, Straubinger RM, Gillard B, Foster BA, Rajan P, Attwood K, Chatley S, Iyer R, Fountzilas C, Bakin AV (2024) A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers. Cell Rep Med 5(3):101434. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101434","journal-title":"Cell Rep Med"},{"key":"5250_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24152772","volume":"24","author":"A Balkrishna","year":"2019","unstructured":"Balkrishna A, Das SK, Pokhrel S, Joshi A, Verma S, Sharma VK, Sharma V, Sharma N, Joshi CS (2019) Colchicine: isolation, LC-MS QTof screening, and anticancer activity study of Gloriosa superba seeds. Molecules 24:31366123. https:\/\/doi.org\/10.3390\/molecules24152772","journal-title":"Molecules"},{"key":"5250_CR4","doi-asserted-by":"publisher","first-page":"10653","DOI":"10.1007\/s13277-016-4972-7","volume":"37","author":"S Bhattacharya","year":"2016","unstructured":"Bhattacharya S, Das A, Datta S, Ganguli A, Chakrabarti G (2016) Colchicine induces autophagy and senescence in lung cancer cells at clinically admissible concentration: potential use of colchicine in combination with autophagy inhibitor in cancer therapy. Tumour Biol 37:10653\u201310664. https:\/\/doi.org\/10.1007\/s13277-016-4972-7","journal-title":"Tumour Biol"},{"key":"5250_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"5250_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1568010053622984","volume":"4","author":"C Cerquaglia","year":"2005","unstructured":"Cerquaglia C, Diaco M, Nucera G, La Regina M, Montalto M, Manna R (2005) Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update. Curr Drug Targets Inflamm Allergy 4:117\u2013124. https:\/\/doi.org\/10.2174\/1568010053622984","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"5250_CR7","doi-asserted-by":"publisher","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","volume":"48","author":"L Chang","year":"2020","unstructured":"Chang L, Zhou G, Soufan O, Xia J (2020) miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res 48:W244-w251. https:\/\/doi.org\/10.1093\/nar\/gkaa467","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5250_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15342-4","volume":"7","author":"X Cheng","year":"2017","unstructured":"Cheng X, Peuckert C, W\u00f6lfl S (2017) Essential role of mitochondrial Stat3 in p38(MAPK) mediated apoptosis under oxidative stress. Sci Rep 7(1):15388. https:\/\/doi.org\/10.1038\/s41598-017-15342-4","journal-title":"Sci Rep"},{"key":"5250_CR9","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.biocel.2009.12.014","volume":"42","author":"WC Cho","year":"2010","unstructured":"Cho WC (2010) MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 42:1273\u20131281. https:\/\/doi.org\/10.1016\/j.biocel.2009.12.014","journal-title":"Int J Biochem Cell Biol"},{"key":"5250_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1158\/1541-7786.Mcr-06-0278","volume":"5","author":"FS Chou","year":"2007","unstructured":"Chou FS, Wang PS, Kulp S, Pinzone JJ (2007) Effects of thiazolidinediones on differentiation, proliferation, and apoptosis. Mol Cancer Res 5:523\u2013530. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-06-0278","journal-title":"Mol Cancer Res"},{"key":"5250_CR11","doi-asserted-by":"publisher","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","volume":"46","author":"CH Chou","year":"2018","unstructured":"Chou CH, Shrestha S, Yang CD, Chang NW, Lin YL, Liao KW, Huang WC, Sun TH, Tu SJ, Lee WH, Chiew MY, Tai CS, Wei TY, Tsai TR, Huang HT, Wang CY, Wu HY, Ho SY, Chen PR, Chuang CH, Hsieh PJ, Wu YS, Chen WL, Li MJ, Wu YC, Huang XY, Ng FL, Buddhakosai W, Huang PC, Lan KC, Huang CY, Weng SL, Cheng YN, Liang C, Hsu WL, Huang HD (2018) miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res 46:D296-d302. https:\/\/doi.org\/10.1093\/nar\/gkx1067","journal-title":"Nucleic Acids Res"},{"key":"5250_CR12","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.clinthera.2014.07.017","volume":"36","author":"N Dalbeth","year":"2014","unstructured":"Dalbeth N, Lauterio TJ, Wolfe HR (2014) Mechanism of action of colchicine in the treatment of gout. Clin Ther 36:1465\u20131479. https:\/\/doi.org\/10.1016\/j.clinthera.2014.07.017","journal-title":"Clin Ther"},{"key":"5250_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115547","volume":"22","author":"AK Eichelmann","year":"2021","unstructured":"Eichelmann AK, Mayne GC, Chiam K, Due SL, Bastian I, Butz F, Wang T, Sykes PJ, Clemons NJ, Liu DS, Michael MZ, Karapetis CS, Hummel R, Watson DI, Hussey DJ (2021) Mutant p53 mediates sensitivity to cancer treatment agents in oesophageal adenocarcinoma associated with microRNA and SLC7A11 expression. Int J Mol Sci 22:34074015. https:\/\/doi.org\/10.3390\/ijms22115547","journal-title":"Int J Mol Sci"},{"key":"5250_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101949","volume":"42","author":"L Freire Boullosa","year":"2021","unstructured":"Freire Boullosa L, Van Loenhout J, Flieswasser T, De Waele J, Hermans C, Lambrechts H, Cuypers B, Laukens K, Bartholomeus E, Siozopoulou V, De Vos WH, Peeters M, Smits ELJ, Deben C (2021) Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer. Redox Biol 42:101949. https:\/\/doi.org\/10.1016\/j.redox.2021.101949","journal-title":"Redox Biol"},{"key":"5250_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, Mcdade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, Zhu J, Haussler D (2020) Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol 38:675\u2013678. https:\/\/doi.org\/10.1038\/s41587-020-0546-8","journal-title":"Nat Biotechnol"},{"key":"5250_CR16","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1158\/1541-7786.Mcr-19-0144","volume":"17","author":"MT Goswami","year":"2019","unstructured":"Goswami MT, Vandenberg KR, Han S, Wang LL, Singh B, Weiss T, Barlow M, Kamberov S, Wilder-Romans K, Rhodes DR, Feng FY, Tomlins SA (2019) Identification of TP53RK-Binding Protein (TPRKB) Dependency in TP53-Deficient Cancers. Mol Cancer Res 17:1652\u20131664. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-19-0144","journal-title":"Mol Cancer Res"},{"key":"5250_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","volume":"21","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Karin M (2010) Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21:11\u201319. https:\/\/doi.org\/10.1016\/j.cytogfr.2009.11.005","journal-title":"Cytokine Growth Factor Rev"},{"key":"5250_CR18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/1759-7714.12982","volume":"10","author":"X Guan","year":"2019","unstructured":"Guan X, Fang Y, Long J, Zhang Y (2019) Annexin 1-nuclear factor-\u03baB-microRNA-26a regulatory pathway in the metastasis of non-small cell lung cancer. Thorac Cancer 10:665\u2013675. https:\/\/doi.org\/10.1111\/1759-7714.12982","journal-title":"Thorac Cancer"},{"key":"5250_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/CAD.0b013e328011e67d","volume":"18","author":"S Han","year":"2007","unstructured":"Han S, Roman J (2007) Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics? Anticancer Drugs 18:237\u2013244. https:\/\/doi.org\/10.1097\/CAD.0b013e328011e67d","journal-title":"Anticancer Drugs"},{"key":"5250_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01509","volume":"9","author":"Y He","year":"2018","unstructured":"He Y, Liu H, Jiang L, Rui B, Mei J, Xiao H (2018) MiR-26 induces apoptosis and inhibits autophagy in non-small cell lung cancer cells by suppressing TGF-\u03b21-JNK signaling pathway. Front Pharmacol 9:1509. https:\/\/doi.org\/10.3389\/fphar.2018.01509","journal-title":"Front Pharmacol"},{"issue":"6","key":"5250_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211014989","volume":"49","author":"F He","year":"2021","unstructured":"He F, Wang G, Xu Z, Huang Z (2021) Nelfinavir restricts A549 cell growth by inhibiting STAT3 signaling. J Int Med Res 49(6):3000605211014989. https:\/\/doi.org\/10.1177\/03000605211014989","journal-title":"J Int Med Res"},{"key":"5250_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","volume":"33","author":"T Hirano","year":"2021","unstructured":"Hirano T (2021) IL-6 in inflammation, autoimmunity and cancer. Int Immunol 33:127\u2013148. https:\/\/doi.org\/10.1093\/intimm\/dxaa078","journal-title":"Int Immunol"},{"key":"5250_CR23","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/jrr\/rraa062","volume":"61","author":"L Hu","year":"2020","unstructured":"Hu L, Chen H, Zhang X, Feng Z, Zhang H, Meng Q (2020) Rosiglitazone ameliorates radiation-induced intestinal inflammation in rats by inhibiting NLRP3 inflammasome and TNF-\u03b1 production. J Radiat Res 61:842\u2013850. https:\/\/doi.org\/10.1093\/jrr\/rraa062","journal-title":"J Radiat Res"},{"key":"5250_CR24","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.3892\/mmr.2015.4222","volume":"12","author":"Z Huang","year":"2015","unstructured":"Huang Z, Xu Y, Peng W (2015) Colchicine induces apoptosis in HT-29 human colon cancer cells via the AKT and c-Jun N-terminal kinase signaling pathways. Mol Med Rep 12:5939\u20135944. https:\/\/doi.org\/10.3892\/mmr.2015.4222","journal-title":"Mol Med Rep"},{"key":"5250_CR25","first-page":"424","volume":"10","author":"SK Hwang","year":"2020","unstructured":"Hwang SK, Jeong YJ, Chang YC (2020) PDCD4 inhibits lung tumorigenesis by the suppressing p62-Nrf2 signaling pathway and upregulating Keap1 expression. Am J Cancer Res 10:424\u2013439","journal-title":"Am J Cancer Res"},{"key":"5250_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1158\/1535-7163.Mct-15-0519","volume":"15","author":"NA Jabbour-Leung","year":"2016","unstructured":"Jabbour-Leung NA, Chen X, Bui T, Jiang Y, Yang D, Vijayaraghavan S, Mcarthur MJ, Hunt KK, Keyomarsi K (2016) Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer. Mol Cancer Ther 15:593\u2013607. https:\/\/doi.org\/10.1158\/1535-7163.Mct-15-0519","journal-title":"Mol Cancer Ther"},{"key":"5250_CR27","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1349-7006.2007.00713.x","volume":"99","author":"X Jin","year":"2008","unstructured":"Jin X, Wang Z, Qiu L, Zhang D, Guo Z, Gao Z, Deng C, Wang F, Wang S, Guo C (2008) Potential biomarkers involving IKK\/RelA signal in early stage non-small cell lung cancer. Cancer Sci 99:582\u2013589. https:\/\/doi.org\/10.1111\/j.1349-7006.2007.00713.x","journal-title":"Cancer Sci"},{"key":"5250_CR28","doi-asserted-by":"publisher","unstructured":"Jing H, Lee S (2014) NF-\u03baB in cellular senescence and cancer treatment. Mol Cells 37:189\u201395. https:\/\/doi.org\/10.14348\/molcells.2014.2353","DOI":"10.14348\/molcells.2014.2353"},{"key":"5250_CR29","doi-asserted-by":"publisher","first-page":"D239","DOI":"10.1093\/nar\/gkx1141","volume":"46","author":"D Karagkouni","year":"2018","unstructured":"Karagkouni D, Paraskevopoulou MD, Chatzopoulos S, Vlachos IS, Tastsoglou S, Kanellos I, Papadimitriou D, Kavakiotis I, Maniou S, Skoufos G, Vergoulis T, Dalamagas T, Hatzigeorgiou AG (2018) DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Res 46:D239-d245. https:\/\/doi.org\/10.1093\/nar\/gkx1141","journal-title":"Nucleic Acids Res"},{"key":"5250_CR30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/s41388-021-02141-5","volume":"41","author":"B Klimovich","year":"2022","unstructured":"Klimovich B, Merle N, Neumann M, Elmsh\u00e4user S, Nist A, Mernberger M, Kazdal D, Stenzinger A, Timofeev O, Stiewe T (2022) p53 partial loss-of-function mutations sensitize to chemotherapy. Oncogene 41:1011\u20131023. https:\/\/doi.org\/10.1038\/s41388-021-02141-5","journal-title":"Oncogene"},{"key":"5250_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells13121007","volume":"13","author":"K Kosi\u0144ska","year":"2024","unstructured":"Kosi\u0144ska K, Sk\u00f3ra B, Holota S, Shepeta Y, Tab\u0119cka-\u0141onczy\u0144ska A, Lesyk R, Szychowski KA (2024) Role of 4-thiazolidinone-pyrazoline\/indoline hybrids Les-4369 and Les-3467 in BJ and A549 cell lines. Cells 13:38920636. https:\/\/doi.org\/10.3390\/cells13121007","journal-title":"Cells"},{"key":"5250_CR32","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S (2019) Mirbase: from microrna sequences to function. Nucleic Acids Res 47:D155-d162. https:\/\/doi.org\/10.1093\/nar\/gky1141","journal-title":"Nucleic Acids Res"},{"key":"5250_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mad.2014.06.002","volume":"139","author":"M Krze\u015bniak","year":"2014","unstructured":"Krze\u015bniak M, Zajkowicz A, Matuszczyk I, Rusin M (2014) Rapamycin prevents strong phosphorylation of p53 on serine 46 and attenuates activation of the p53 pathway in A549 lung cancer cells exposed to actinomycin D. Mech Ageing Dev 139:11\u201321. https:\/\/doi.org\/10.1016\/j.mad.2014.06.002","journal-title":"Mech Ageing Dev"},{"issue":"3","key":"5250_CR34","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/cad.0000000000000464","volume":"28","author":"A Kumar","year":"2017","unstructured":"Kumar A, Sharma PR, Mondhe DM (2017) Potential anticancer role of colchicine-based derivatives: an overview. Anticancer Drugs 28(3):250\u2013262. https:\/\/doi.org\/10.1097\/cad.0000000000000464","journal-title":"Anticancer Drugs"},{"key":"5250_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88260-1","volume":"11","author":"J Kurek","year":"2021","unstructured":"Kurek J, Myszkowski K, Okulicz-Kozaryn I, Kurant A, Kami\u0144ska E, Szulc M, Rubi\u015b B, Kaczmarek M, Miko\u0142ajczak P, Murias M (2021) Cytotoxic, analgesic and anti-inflammatory activity of colchicine and its C-10 sulfur containing derivatives. Sci Rep 11:9034. https:\/\/doi.org\/10.1038\/s41598-021-88260-1","journal-title":"Sci Rep"},{"issue":"2","key":"5250_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.molonc.2013.02.010","volume":"7","author":"MC Kwon","year":"2013","unstructured":"Kwon MC, Berns A (2013) Mouse models for lung cancer. Mol Oncol 7(2):165\u2013177. https:\/\/doi.org\/10.1016\/j.molonc.2013.02.010","journal-title":"Mol Oncol"},{"key":"5250_CR37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/bf02255920","volume":"7","author":"SL Lai","year":"2000","unstructured":"Lai SL, Perng RP, Hwang J (2000) P53 gene status modulates the chemosensitivity of non-small cell lung cancer cells. J Biomed Sci 7:64\u201370. https:\/\/doi.org\/10.1007\/bf02255920","journal-title":"J Biomed Sci"},{"key":"5250_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141020","volume":"10","author":"J Laukov\u00e1","year":"2015","unstructured":"Laukov\u00e1 J, Kozub\u00edk A, Hofmanov\u00e1 J, Nekvindov\u00e1 J, Sova P, Moyer MP, Ehrmann J, Hyr\u0161lov\u00e1 Vaculov\u00e1 A (2015) Loss of PTEN facilitates rosiglitazone-mediated enhancement of platinum(IV) complex LA-12-induced apoptosis in colon cancer cells. PLoS ONE 10:e0141020. https:\/\/doi.org\/10.1371\/journal.pone.0141020","journal-title":"PLoS ONE"},{"key":"5250_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.lungcan.2005.10.010","volume":"51","author":"SY Lee","year":"2006","unstructured":"Lee SY, Hur GY, Jung KH, Jung HC, Lee SY, Kim JH, Shin C, Shim JJ, In KH, Kang KH, Yoo SH (2006) PPAR-gamma agonist increase gefitinib\u2019s antitumor activity through PTEN expression. Lung Cancer 51:297\u2013301. https:\/\/doi.org\/10.1016\/j.lungcan.2005.10.010","journal-title":"Lung Cancer"},{"key":"5250_CR40","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1038\/sj.emboj.7601900","volume":"26","author":"CH Lee","year":"2007","unstructured":"Lee CH, Inoki K, Karbowniczek M, Petroulakis E, Sonenberg N, Henske EP, Guan KL (2007) Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53. EMBO J 26:4812\u20134823. https:\/\/doi.org\/10.1038\/sj.emboj.7601900","journal-title":"EMBO J"},{"issue":"8","key":"5250_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/1010428318794217","volume":"40","author":"YS Lee","year":"2018","unstructured":"Lee YS, Choi JY, Lee J, Shim DM, Kim J, Park WY, Nam DH, Seo SW (2018) TP53-dependence on the effect of doxorubicin and Src inhibitor combination therapy. Tumour Biol 40(8):1010428318794217. https:\/\/doi.org\/10.1177\/1010428318794217","journal-title":"Tumour Biol"},{"key":"5250_CR42","first-page":"692","volume":"13","author":"H Li","year":"2020","unstructured":"Li H, Zhao J, Jia X, Zhang Y, Du Y, Li H, Ma L, Huang J (2020) miR-21 promotes growth, invasion and migration of lung cancer cells by AKT\/P-AKT\/cleaved-caspase 3\/MMP-2\/MMP-9 signaling pathway. Int J Clin Exp Pathol 13:692\u2013700","journal-title":"Int J Clin Exp Pathol"},{"key":"5250_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/787924","volume":"2014","author":"CF Lin","year":"2014","unstructured":"Lin CF, Young KC, Bai CH, Yu BC, Ma CT, Chien YC, Chiang CL, Liao CS, Lai HW, Tsao CW (2014) Rosiglitazone regulates anti-inflammation and growth inhibition via PTEN. Biomed Res Int 2014:787924. https:\/\/doi.org\/10.1155\/2014\/787924","journal-title":"Biomed Res Int"},{"key":"5250_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102063","volume":"298","author":"Z Liu","year":"2022","unstructured":"Liu Z, Huang L, Zhou T, Chang X, Yang Y, Shi Y, Hao M, Li Z, Wu Y, Guan Q, Zhang W, Zuo D (2022) A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non-small cell lung cancers. J Biol Chem 298:102063. https:\/\/doi.org\/10.1016\/j.jbc.2022.102063","journal-title":"J Biol Chem"},{"issue":"1","key":"5250_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1748-7188-6-26","volume":"6","author":"R Lorenz","year":"2011","unstructured":"Lorenz R, Bernhart SH, H\u00f6ner Zu Siederdissen C, Tafer H, Flamm C, Stadler PF, Hofacker IL (2011) ViennaRNA Package 2.0. Algorithms Mol Biol 6(1):26. https:\/\/doi.org\/10.1186\/1748-7188-6-26","journal-title":"Algorithms Mol Biol"},{"issue":"5","key":"5250_CR46","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.3892\/mmr.2017.6331","volume":"15","author":"Z Lu","year":"2017","unstructured":"Lu Z, Xiao Y, Liu X, Zhang Z, Xiao F, Bi Y (2017) Matrine reduces the proliferation of A549\u00a0cells via the p53\/p21\/PCNA\/eIF4E signaling pathway. Mol Med Rep 15(5):2415\u20132422. https:\/\/doi.org\/10.3892\/mmr.2017.6331","journal-title":"Mol Med Rep"},{"key":"5250_CR47","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00204-017-2141-4","volume":"92","author":"YY Lu","year":"2018","unstructured":"Lu YY, Lin Y, Ding DX, Su S, Chi QQ, Zhang YC, Sun J, Zhang X, Zhu HM, Huang QS, Chi YL, Ye GZ, Tao S, Dong SJ (2018) Mir-26a functions as a tumor suppressor in ambient particulate matter-bound metal-triggered lung cancer cell metastasis by targeting LIN28B-IL6-STAT3 axis. Arch Toxicol 92:1023\u20131035. https:\/\/doi.org\/10.1007\/s00204-017-2141-4","journal-title":"Arch Toxicol"},{"issue":"5","key":"5250_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063906","volume":"8","author":"S Lyskov","year":"2013","unstructured":"Lyskov S, Chou FC, Conch\u00fair S, Der BS, Drew K, Kuroda D, Xu J, Weitzner BD, Renfrew PD, Sripakdeevong P, Borgo B, Havranek JJ, Kuhlman B, Kortemme T, Bonneau R, Gray JJ, Das R (2013) Serverification of molecular modeling applications: the Rosetta online server that includes everyone (ROSIE). PLoS ONE 8(5):e63906. https:\/\/doi.org\/10.1371\/journal.pone.0063906","journal-title":"PLoS ONE"},{"key":"5250_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216608","volume":"584","author":"FP Madorsky Rowdo","year":"2024","unstructured":"Madorsky Rowdo FP, Xiao G, Khramtsova GF, Nguyen J, Martini R, Stonaker B, Boateng R, Oppong JK, Adjei EK, Awuah B, Kyei I, Aitpillah FS, Adinku MO, Ankomah K, Osei-Bonsu EB, Gyan KK, Altorki NK, Cheng E, Ginter PS, Hoda S, Newman L, Elemento O, Olopade OI, Davis MB, Martin ML, Bargonetti J (2024) Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment. Cancer Lett 584:216608. https:\/\/doi.org\/10.1016\/j.canlet.2024.216608","journal-title":"Cancer Lett"},{"key":"5250_CR50","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1183\/13993003.00359-2016","volume":"48","author":"J Malhotra","year":"2016","unstructured":"Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P (2016) Risk factors for lung cancer worldwide. Eur Respir J 48:889\u2013902. https:\/\/doi.org\/10.1183\/13993003.00359-2016","journal-title":"Eur Respir J"},{"key":"5250_CR51","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/978-3-030-34025-4_20","volume":"1219","author":"N Mendes","year":"2020","unstructured":"Mendes N, Dias Carvalho P, Martins F, Mendon\u00e7a S, Malheiro AR, Ribeiro A, Carvalho J, Velho S (2020) Animal models to study cancer and its microenvironment. Adv Exp Med Biol 1219:389\u2013401. https:\/\/doi.org\/10.1007\/978-3-030-34025-4_20","journal-title":"Adv Exp Med Biol"},{"key":"5250_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4792","volume":"32","author":"EC Meng","year":"2023","unstructured":"Meng EC, Goddard TD, Pettersen EF, Couch GS, Pearson ZJ, Morris JH, Ferrin TE (2023) UCSF chimeraX: tools for structure building and analysis. Protein Sci 32:e4792. https:\/\/doi.org\/10.1002\/pro.4792","journal-title":"Protein Sci"},{"key":"5250_CR53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.lungcan.2013.11.001","volume":"83","author":"VS Nair","year":"2014","unstructured":"Nair VS, Gevaert O, Davidzon G, Plevritis SK, West R (2014) NF-\u03baB protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism. Lung Cancer 83:189\u2013196. https:\/\/doi.org\/10.1016\/j.lungcan.2013.11.001","journal-title":"Lung Cancer"},{"key":"5250_CR54","doi-asserted-by":"publisher","first-page":"8969","DOI":"10.1128\/mcb.20.23.8969-8982.2000","volume":"20","author":"N Nakamura","year":"2000","unstructured":"Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR (2000) Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 20:8969\u20138982. https:\/\/doi.org\/10.1128\/mcb.20.23.8969-8982.2000","journal-title":"Mol Cell Biol"},{"key":"5250_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1260776","volume":"10","author":"N Ogarek","year":"2023","unstructured":"Ogarek N, Oboza P, Olszanecka-Glinianowicz M, Kocelak P (2023) Sars-CoV-2 infection as a potential risk factor for the development of cancer. Front Mol Biosci 10:1260776. https:\/\/doi.org\/10.3389\/fmolb.2023.1260776","journal-title":"Front Mol Biosci"},{"key":"5250_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-016-0815-z","volume":"33","author":"D Pastuszak-Lewandoska","year":"2016","unstructured":"Pastuszak-Lewandoska D, Kordiak J, Czarnecka KH, Migdalska-S\u0119k M, Nawrot E, Doma\u0144ska-Senderowska D, Kisza\u0142kiewicz JM, Antczak A, G\u00f3rski P, Brzezia\u0144ska-Lasota E (2016) Expression analysis of three miRNAs, miR-26a, miR-29b and miR-519d, in relation to MMP-2 expression level in non-small cell lung cancer patients: a pilot study. Med Oncol 33:96. https:\/\/doi.org\/10.1007\/s12032-016-0815-z","journal-title":"Med Oncol"},{"key":"5250_CR57","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/1759-7714.12345","volume":"7","author":"H Qin","year":"2016","unstructured":"Qin H, Zhou J, Zhou P, Xu J, Tang Z, Ma H, Guo F (2016) Prognostic significance of RelB overexpression in non-small cell lung cancer patients. Thorac Cancer 7:415\u2013421. https:\/\/doi.org\/10.1111\/1759-7714.12345","journal-title":"Thorac Cancer"},{"key":"5250_CR58","doi-asserted-by":"publisher","unstructured":"Qu R, Zhao Y, Zhang Y (2024) The mechanism of cytokine regulation of cancer occurrence and development in the tumor microenvironment and its application in cancer treatment: a narrative review. Transl Cancer Res 13:5649\u20135663. https:\/\/doi.org\/10.21037\/tcr-24-679","DOI":"10.21037\/tcr-24-679"},{"issue":"7","key":"5250_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"key":"5250_CR60","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2147\/copd.S453593","volume":"19","author":"X Sai","year":"2024","unstructured":"Sai X, Qin C, Zhang Z, Yu H, Bian T (2024) A miRNA-21-Mediated PTEN\/Akt\/NF-\u03baB Axis Promotes Chronic Obstructive Pulmonary Disease Pathogenesis. Int J Chron Obstruct Pulmon Dis 19:1141\u20131151. https:\/\/doi.org\/10.2147\/copd.S453593","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"5250_CR61","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1002\/jcb.29489","volume":"121","author":"F Song","year":"2020","unstructured":"Song F, Xuan Z, Yang X, Ye X, Pan Z, Fang Q (2020) Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses. J Cell Biochem 121:2690\u20132703. https:\/\/doi.org\/10.1002\/jcb.29489","journal-title":"J Cell Biochem"},{"key":"5250_CR62","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, Jensen LJ, Von Mering C (2021) The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res 49:D605-d612. https:\/\/doi.org\/10.1093\/nar\/gkaa1074","journal-title":"Nucleic Acids Res"},{"key":"5250_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111684","volume":"139","author":"KA Szychowski","year":"2021","unstructured":"Szychowski KA, Sk\u00f3ra B, Kryshchyshyn-Dylevych A, Kaminskyy D, Khyluk D, Lesyk R (2021) 4-thiazolidinone-based derivatives rosiglitazone and pioglitazone affect the expression of antioxidant enzymes in different human cell lines. Biomed Pharmacother 139:111684. https:\/\/doi.org\/10.1016\/j.biopha.2021.111684","journal-title":"Biomed Pharmacother"},{"key":"5250_CR64","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1126\/science.280.5369.1614","volume":"280","author":"M Tamura","year":"1998","unstructured":"Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614\u20131617. https:\/\/doi.org\/10.1126\/science.280.5369.1614","journal-title":"Science"},{"key":"5250_CR65","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Karin M (2018) NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 18:309\u2013324. https:\/\/doi.org\/10.1038\/nri.2017.142","journal-title":"Nat Rev Immunol"},{"key":"5250_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.734450","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Wu Q, Ding L, Song S, Li Y, Shi L, Wang T, Zhao D, Wang Z, Li X (2021) Therapeutic effects and molecular mechanisms of bioactive compounds against respiratory diseases: traditional Chinese medicine theory and high-frequency use. Front Pharmacol 12:734450. https:\/\/doi.org\/10.3389\/fphar.2021.734450","journal-title":"Front Pharmacol"},{"key":"5250_CR67","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1093\/nar\/gkp117","volume":"37","author":"NS Wickramasinghe","year":"2009","unstructured":"Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM (2009) Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 37:2584\u20132595. https:\/\/doi.org\/10.1093\/nar\/gkp117","journal-title":"Nucleic Acids Res"},{"key":"5250_CR68","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams CJ, Headd JJ, Moriarty NW, Prisant MG, Videau LL, Deis LN, Verma V, Keedy DA, Hintze BJ, Chen VB, Jain S, Lewis SM, Arendall WB 3rd, Snoeyink J, Adams PD, Lovell SC, Richardson JS, Richardson DC (2018) MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci 27:293\u2013315. https:\/\/doi.org\/10.1002\/pro.3330","journal-title":"Protein Sci"},{"key":"5250_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004497","volume":"7","author":"M Xiang","year":"2014","unstructured":"Xiang M, Birkbak NJ, Vafaizadeh V, Walker SR, Yeh JE, Liu S, Kroll Y, Boldin M, Taganov K, Groner B, Richardson AL, Frank DA (2014) STAT3 induction of mir-146b forms a feedback loop to inhibit the NF-\u03bab to IL-6 signaling axis and STAT3-driven cancer phenotypes. Sci Signal 7:ra11. https:\/\/doi.org\/10.1126\/scisignal.2004497","journal-title":"Sci Signal"},{"key":"5250_CR70","doi-asserted-by":"publisher","first-page":"D105","DOI":"10.1093\/nar\/gkn851","volume":"37","author":"F Xiao","year":"2009","unstructured":"Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 37:D105\u2013D110. https:\/\/doi.org\/10.1093\/nar\/gkn851","journal-title":"Nucleic Acids Res"},{"key":"5250_CR71","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.3892\/etm.2018.6752","volume":"16","author":"L Yan","year":"2018","unstructured":"Yan L, Ma J, Wang Y, Zan J, Wang Z, Zhu Y, Zhu Y, Ling L, Cao L, Liu X, Li S, Xu L, Qi Z, Nie L, Zhang Y (2018) miR-21-5p induces cell proliferation by targeting TGFBI in non-small cell lung cancer cells. Exp Ther Med 16:4655\u20134663. https:\/\/doi.org\/10.3892\/etm.2018.6752","journal-title":"Exp Ther Med"},{"key":"5250_CR72","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/hep.26305","volume":"58","author":"X Yang","year":"2013","unstructured":"Yang X, Liang L, Zhang XF, Jia HL, Qin Y, Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, Wei JW, Zhou HJ, Ren N, Ye QH, Dong QZ, Qin LX (2013) MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology 58:158\u2013170. https:\/\/doi.org\/10.1002\/hep.26305","journal-title":"Hepatology"},{"key":"5250_CR73","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2147\/cmar.S171517","volume":"11","author":"L Yang","year":"2019","unstructured":"Yang L, Li J, Xu L, Lin S, Xiang Y, Dai X, Liang G, Huang X, Zhu J, Zhao C (2019) Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway. Cancer Manag Res 11:1167\u20131176. https:\/\/doi.org\/10.2147\/cmar.S171517","journal-title":"Cancer Manag Res"},{"key":"5250_CR74","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cbpa.2019.01.024","volume":"51","author":"Q Yao","year":"2019","unstructured":"Yao Q, Chen Y, Zhou X (2019) The roles of microRNAs in epigenetic regulation. Curr Opin Chem Biol 51:11\u201317. https:\/\/doi.org\/10.1016\/j.cbpa.2019.01.024","journal-title":"Curr Opin Chem Biol"},{"key":"5250_CR75","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1038\/onc.2011.517","volume":"31","author":"S Yoon","year":"2012","unstructured":"Yoon S, Woo SU, Kang JH, Kim K, Shin HJ, Gwak HS, Park S, Chwae YJ (2012) NF-\u03baB and STAT3 cooperatively induce IL6 in starved cancer cells. Oncogene 31:3467\u20133481. https:\/\/doi.org\/10.1038\/onc.2011.517","journal-title":"Oncogene"},{"key":"5250_CR76","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9:798\u2013809. https:\/\/doi.org\/10.1038\/nrc2734","journal-title":"Nat Rev Cancer"},{"key":"5250_CR77","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1158\/1078-0432.Ccr-10-3168","volume":"17","author":"R Zandi","year":"2011","unstructured":"Zandi R, Selivanova G, Christensen CL, Gerds TA, Willumsen BM, Poulsen HS (2011) PRIMA-1Met\/APR-246 induces apoptosis and tumor growth delay in small cell lung cancer expressing mutant p53. Clin Cancer Res 17:2830\u20132841. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-10-3168","journal-title":"Clin Cancer Res"},{"key":"5250_CR78","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41577-019-0151-6","volume":"19","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Cao X (2019) Epigenetic regulation of the innate immune response to infection. Nat Rev Immunol 19:417\u2013432. https:\/\/doi.org\/10.1038\/s41577-019-0151-6","journal-title":"Nat Rev Immunol"},{"key":"5250_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-021-00341-5","volume":"10","author":"J Zhang","year":"2022","unstructured":"Zhang J, Veeramachaneni N (2022) Targeting interleukin-1\u03b2 and inflammation in lung cancer. Biomark Res 10:5. https:\/\/doi.org\/10.1186\/s40364-021-00341-5","journal-title":"Biomark Res"},{"key":"5250_CR80","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cca.2010.02.074","volume":"411","author":"JG Zhang","year":"2010","unstructured":"Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, Yang GH (2010) MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 411:846\u2013852. https:\/\/doi.org\/10.1016\/j.cca.2010.02.074","journal-title":"Clin Chim Acta"},{"key":"5250_CR81","doi-asserted-by":"crossref","unstructured":"Zhang T, Chen W, Jiang X, Liu L, Wei K, Du H, Wang H, Li J (2019) Anticancer effects and underlying mechanism of Colchicine on human gastric cancer cell lines in vitro and in vivo. Biosci Rep 39:10.1042\/bsr20181802 PMID:30429232","DOI":"10.1042\/BSR20181802"},{"key":"5250_CR82","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.soc.2016.02.003","volume":"25","author":"M Zheng","year":"2016","unstructured":"Zheng M (2016) Classification and Pathology of Lung Cancer. Surg Oncol Clin N Am 25:447\u2013468. https:\/\/doi.org\/10.1016\/j.soc.2016.02.003","journal-title":"Surg Oncol Clin N Am"},{"key":"5250_CR83","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10175","volume":"22","author":"JP Zhou","year":"2021","unstructured":"Zhou JP, Yang XN, Song Y, Zhou F, Liu JJ, Hu YQ, Chen LG (2021) Rosiglitazone alleviates lipopolysaccharide-induced inflammation in RAW264.7 cells via inhibition of NF-\u03bab and in a PPAR\u03b3-dependent manner. Exp Ther Med 22:743. https:\/\/doi.org\/10.3892\/etm.2021.10175","journal-title":"Exp Ther Med"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05250-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05250-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05250-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:59:56Z","timestamp":1784775596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05250-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":83,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5250"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05250-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}